Margaret was 71, a retired librarian in Tucson, Arizona, who had been on lithium for forty-three years for bipolar I disorder. Her psychiatrist had retired the previous winter, and her primary care physician inherited the prescription without much review. In late August, during a heatwave, her cardiologist added lisinopril for blood pressure and a low-dose ibuprofen for joint pain. Two weeks later her daughter found her in the kitchen unable to remember the names of her grandchildren. Her hands shook so badly she could not hold a glass. The ER drew a lithium level of 2.8 mEq/L, a creatinine that had doubled, and a sodium of 132. The toxicology fellow on call recognised the perfect storm of lithium plus a heatwave plus an ACE inhibitor plus an NSAID plus an aging kidney, and recommended urgent lithium toxicity treatment with hemodialysis. Margaret was on a dialysis machine within four hours, off lithium for the first time in four decades, and at home eight days later, slower than she had been but back to herself, with a chart her daughter now reviews quarterly.
The narrowest therapeutic window in psychiatry
Lithium has been the most effective mood stabiliser for bipolar disorder since the 1960s. It also has one of the narrowest therapeutic indices of any drug in routine use. Maintenance levels sit at 0.6–1.2 mEq/L. Toxicity begins around 1.5 mEq/L. Severe toxicity at 2.5 mEq/L. Life-threatening toxicity above 3.5 mEq/L. The gap between therapeutic and dangerous is sometimes a single missed water bottle on a hot day. Effective lithium toxicity treatment rests on understanding how easily that gap closes.
Lithium is renally cleared, with no metabolism. Anything that reduces glomerular filtration or raises proximal tubule sodium reabsorption raises lithium levels, sometimes dramatically. Dehydration, low-sodium diets, kidney disease, and the prescription drug class that interferes most predictably (NSAIDs, ACE inhibitors, ARBs, thiazide diuretics) are the daily culprits.
Symptom progression by severity
Lithium toxicity follows a predictable trajectory if you know what to look for.
- Mild (1.5–2.0 mEq/L): fine tremor that worsens at the fingertips, mild nausea, diarrhoea, drowsiness, weakness, mild ataxia
- Moderate (2.0–2.5 mEq/L): coarse tremor, vomiting, pronounced confusion, dysarthria, hyperreflexia, fasciculations, ataxic gait, blurred vision, tinnitus
- Severe (2.5–3.5 mEq/L): stupor, seizures, myoclonus, choreoathetoid movements, autonomic instability, hyperthermia, oliguria
- Life-threatening (above 3.5 mEq/L): coma, generalised seizures, cardiovascular collapse, ventricular arrhythmias, permanent neurological injury
Symptom severity does not always match the level. Patients on chronic lithium develop intracellular accumulation that may produce significant neurotoxicity at modest serum levels. A patient with chronic toxicity at 2.0 mEq/L can appear sicker than a patient with acute overdose at 4.0 mEq/L because the chronic patient’s brain has been saturated for days.
Acute vs. chronic toxicity
The two patterns of lithium toxicity behave differently.
- Acute toxicity: deliberate or accidental overdose in a patient not previously on lithium; serum levels can be very high but tissue distribution is limited; gastrointestinal symptoms dominate early; CNS symptoms develop hours later as redistribution occurs
- Chronic toxicity: gradual accumulation in a patient on stable dosing whose clearance has dropped or whose intake has risen; neurological symptoms dominate from the outset; serum level may be only moderately elevated; long-term outcome is worse because tissue burden is higher
- Acute-on-chronic: chronic user takes additional doses (deliberately or not); the most lethal of the three patterns
The clinical implication is that the chronic toxicity patient often gets dialysed at lower serum levels than the acute overdose patient because the brain burden, not the serum level, determines outcome. Margaret in our opening was a textbook acute-on-chronic case driven by predictable interactions.
The risk factors that almost always precede a case
Reviewing chart after chart of toxicity admissions reveals the same risk clusters.
- NSAIDs, particularly ibuprofen and naproxen, raising lithium levels 25–60 percent within a week
- ACE inhibitors and ARBs added by a cardiologist who did not know about the lithium
- Thiazide diuretics, which deplete sodium and reduce lithium clearance
- Dehydration from heat, gastroenteritis, or starting a low-carb diet that becomes a low-fluid diet
- Low-sodium diets recommended for hypertension
- Age-related decline in glomerular filtration rate that has not been factored into dosing
- New chronic kidney disease from any cause
- Bariatric surgery altering absorption
- Drug interactions with metronidazole and verapamil
- Switching from extended-release to immediate-release formulations without dose adjustment
The patient’s own awareness is one of the strongest protective factors. People who have taken lithium for decades often recognise the early tremor or the unusual nausea before any clinician does. Educating long-term lithium patients about red-flag symptoms and the drugs to avoid is one of the highest-yield outpatient interventions in psychiatry.
Initial management in the emergency department
The first hour matters. Steps any clinician should take when toxicity is suspected:
- Stop lithium immediately
- Stop NSAIDs, ACE inhibitors, ARBs, and thiazides if present
- Draw a serum lithium level immediately and again at 4 hours; in acute overdose, repeat every 2 hours until trending down
- Check basic metabolic panel, magnesium, calcium, urinalysis, and ECG
- Begin aggressive isotonic saline at 200–300 mL/hour, monitoring sodium
- Avoid hypotonic fluids; correcting hyponatraemia too fast risks osmotic demyelination
- For acute ingestions within 1–2 hours, consider whole-bowel irrigation with polyethylene glycol if the patient is alert; activated charcoal does not bind lithium
- Place a Foley catheter to monitor urine output
- Consult nephrology and toxicology early, even before dialysis is decided
Saline forces lithium excretion through dilution and improved renal perfusion. It is the cornerstone of mild-to-moderate cases and is sufficient for a meaningful share of presentations without dialysis.
When dialysis is required: the EXTRIP framework
The Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup published consensus recommendations for hemodialysis in lithium toxicity that have largely standardised practice. Dialysis is recommended when:
- Serum lithium above 4.0 mEq/L regardless of symptoms
- Serum lithium above 2.5 mEq/L with severe symptoms (decreased consciousness, seizures, life-threatening dysrhythmias)
- Serum lithium above 1.5 mEq/L with significant kidney injury or inability to tolerate fluid resuscitation
- Predicted clearance time exceeding 36 hours given current renal function
Hemodialysis clears lithium efficiently, removing roughly 100 mL/min compared to 10–40 mL/min by native kidneys. Sessions typically run 4–8 hours. The challenge is rebound: lithium redistributes from tissue to blood after a session ends, and serum levels often climb again within hours. Continuous renal replacement therapy or repeat intermittent hemodialysis is sometimes required to manage rebound.
Charcoal hemoperfusion does not help. Peritoneal dialysis is too slow. Continuous venovenous hemofiltration is an alternative for haemodynamically unstable patients but clears lithium less efficiently than intermittent hemodialysis. The treating team should plan for sequential treatments rather than a single rescue session.
Monitoring requirements for chronic lithium use
The maintenance monitoring schedule is straightforward when followed. The catch is that over decades, prescribers retire, patients move, and the cadence drifts.
- 12-hour trough lithium level every 6–12 months once stable
- Basic metabolic panel and creatinine every 6 months
- Thyroid function (TSH, free T4) every 6 months because lithium-induced hypothyroidism is common
- Calcium annually because of risk for hyperparathyroidism
- Urinalysis annually for early diabetes insipidus
- Level rechecked 5–7 days after any dose change or any new interacting medication
- Closer monitoring during pregnancy, surgery, intercurrent illness, and weight changes
Patients should keep a wallet card listing their lithium dose and the interacting drug categories to avoid. Any clinician adding a new medication should ask, “Are you on lithium?” and confirm before prescribing NSAIDs, ACE inhibitors, ARBs, or thiazides. The medication safety habits taught in inpatient settings often need reinforcement at every outpatient visit.
After the toxicity: restarting lithium and alternatives
About one in three patients who survive a serious toxicity episode have permanent neurological sequelae, sometimes called syndrome of irreversible lithium-effectuated neurotoxicity (SILENT). Tremor, ataxia, and cognitive dysfunction can persist months or years. The presence of SILENT often pushes the post-recovery decision toward an alternative mood stabiliser.
For patients who restart, dose reduction by 25–50 percent, more frequent monitoring, and a hard stop on interacting medications are essential. For patients who switch, valproate, lamotrigine (for bipolar depression more than mania), and atypical antipsychotics like quetiapine are the usual alternatives. The trade-off is that lithium remains the only mood stabiliser proven to reduce suicide risk in bipolar disorder, and that protective effect is hard to replace.
Pregnancy, breastfeeding, and surgery
Specific clinical situations deserve specific protocols. Pregnancy alters lithium pharmacokinetics dramatically: glomerular filtration rises by the third trimester, lowering levels, and then drops abruptly post-partum, which can push a previously stable woman into toxicity within days of delivery. The standard practice is to monitor levels every 4 weeks early in pregnancy, every 1–2 weeks in the third trimester, hold lithium during active labour, and check a level within 24 hours of delivery before resuming. Breastfeeding is now considered compatible at conservative doses with infant level monitoring, although individual decisions should be made with a perinatal psychiatrist.
Surgery is another high-risk window. Fasting, perioperative dehydration, NSAIDs given for postoperative pain, and acute kidney injury from any cause can push a steady patient toward toxicity in 48–72 hours. Holding lithium for 24–48 hours pre-operatively is usually safe and recommended for major procedures. Restarting requires verification of stable renal function and adequate hydration. Anaesthesia teams should be made aware because lithium can prolong the action of non-depolarising neuromuscular blockers.
The role of patient self-monitoring deserves emphasis. People who have taken lithium for years often track their own tremor as a private barometer; a sudden worsening of fine tremor, new coarse tremor, or a tremor that crosses the wrist into the forearm is frequently the first warning of an early toxicity event. Encouraging patients to keep a brief weekly log, or even a video selfie of an outstretched hand, gives them and their clinician a baseline they can compare against during a hot week or after a new prescription. The same self-monitoring habit catches early thyroid changes (cold intolerance, fatigue) and early diabetes insipidus (excessive thirst, frequent urination) that are otherwise easy to dismiss as ordinary symptoms.
Frequently asked questions
Can I take ibuprofen on lithium?
Occasional doses (1–2 days) are usually tolerated if you check a level afterward. Regular use is contraindicated. Acetaminophen is the safer over-the-counter alternative.
Why does dehydration matter so much?
Dehydration triggers proximal tubular sodium reabsorption, which carries lithium with it. Levels can rise 30 percent or more during a hot day or a stomach bug.
Is one high level dangerous if I feel fine?
Yes. Symptoms can lag the level by hours, particularly in acute ingestion. Any level above 1.5 mEq/L deserves clinical review the same day, even if you feel well.
How quickly does dialysis lower the level?
A single 4–6 hour session typically halves the serum level, but rebound is common. Most patients need 1–3 sessions over 24–48 hours.
Will my kidneys recover after toxicity?
Acute kidney injury usually resolves with hydration and dialysis. Chronic interstitial nephritis from years of lithium exposure may not, and the post-toxicity creatinine can be a useful new baseline.
The bottom line
Lithium remains an extraordinary drug for bipolar disorder, but its therapeutic window is narrow enough that any new medication, any heatwave, any kidney decline can push a steady patient into toxicity. The symptom progression is predictable. The lab cutoffs are well established. The EXTRIP framework tells you when to dialyse. The most preventable cases are the ones where a primary care or specialty clinician adds a routine drug without checking the lithium chart entry. Margaret, the librarian in our opening, kept her lithium with a 25 percent dose reduction, dropped lisinopril for amlodipine, swapped ibuprofen for acetaminophen, and now tells her grandchildren that the kitchen counter has a permanent reminder card.
Anyone in psychiatric crisis can call or text the 988 Suicide and Crisis Lifeline, available 24/7. For drug labelling and pharmacovigilance information, consult the U.S. Food and Drug Administration; the broader medical literature is searchable via the National Institutes of Health.
This article is for educational purposes only and does not constitute medical advice. Suspected lithium toxicity is a medical emergency. Call 911, go to the nearest emergency department, or contact poison control at 1-800-222-1222 immediately, and bring all current medications.